Tharimmune, Inc.
PublicTharimmune, Inc. is now publicly traded
The data on this page reflects Tharimmune, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jan 12, 2022
Last Round
Follow-on Offering
Jan 22, 2026
Est. Valuation at Exit
$164.17M
Total Funding Raised
$624.6M
Company Overview
Canton Strategic Holdings, Inc. is a biotechnology and digital asset treasury company that develops therapeutic candidates for inflammatory and immunologic conditions while operating a digital asset treasury strategy focused on the Canton Network.
AI Layer
Non-AI
Keywords
Tharimmune, Inc. Comparables
Compare Tharimmune, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Pharmaceuticals | 60% | |
| Avior Bio, Inc. | 58% | |
| Aquestive Therapeutics Inc | 54% |
For institutional investors. Book with your work email.
Tharimmune, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jan 22, 2026 | ||||
| Private Placement | Nov 6, 2025 | ||||
| Follow-on Offering | Aug 27, 2025 | ||||
| Private Placement | Jun 13, 2025 | ||||
| Private Placement | Dec 9, 2024 | ||||
Private Placement | Jun 18, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tharimmune, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Feynman Point Asset Management | Private Placement |
| Nima Capital | Private Placement |
| Polychain Capital | Private Placement |
| DRW Trading Group | Private Placement |
| Liberty City Ventures | Private Placement |
| 7Ridge | Private Placement |
| Five North | Private Placement |
For institutional investors. Book with your work email.
Tharimmune, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.